Menu
Enrolling by invitation NCT06141902

The Effects of Jing Si Herbal Tea on Physical and Psychological Symptoms in Peripheral Blood Hematopoietic Stem Cell Donors

No phase Interventional Pain Syndrome Emotional Stress

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Jing Si Herbal Drink.
Who it may be relevant to
Registry conditions: Pain Syndrome, Emotional Stress. Basic parameters: 20 years — 55 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study aim to explore the impact of Jing Si Herbal Tea on pain and emotional stress in peripheral blood stem cell donors.

Interventions

  • Other Jing Si Herbal Drink
    Jing Si Herbal Drink

Primary outcome measures

  • Changes in pain assessed by questionnaires [Time frame: 5 day]
Secondary outcome measures (1)
  • Changes in anxiety assessed by questionnaires [Time frame: 21 days]

Eligibility criteria

Inclusion criteria

  • health Men or women aged 20 to 55 years old
  • willing to take Jing Si Herbal Drink

Exclusion criteria

  • no willing to take Jing Si Herbal Drink;
  • Previously already take Jing Si Herbal Drink daily

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Taiwan · 1 center
  • Hualiien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation — Hualien City

Identifiers

NCT: NCT06141902 · IRB111-125-A · IMAR-111-01-17

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗